1-2010-014EConsensus2010Global

Treatment of type 2 diabetes in Latin America: a consensus statement by the medical associations of 17 Latin American countries

Recommendations71

References49

Pages9

Experts25

LanguageEnglish

Recommendation PresentationExplicit recommendations

Living guidelineNo

UpdatedNo

Rapid adviceNo

Basic Information

Guideline TitleTreatment of type 2 diabetes in Latin America: a consensus statement by the medical associations of 17 Latin American countries

Guideline No.1-2010-014E

AuthorJuan Rosas Guzmán

Guideline TypeConsensus

Year2010

LanguageEnglish

Recommendation PresentationExplicit recommendations

Topic ClassificationTreatment

Target Population2 型糖尿病患者；拉丁美洲人群；肥胖患者；血糖水平<240 mg/dL (13.3 mmol/L) 且 HbA1c < 9% 且临床稳定的患者；血糖水平≥240 mg/dL (13.3 mmol/L) 且 HbA1c ≥ 9% 的患者

Publication and Source

OrganizationPan American Federation of Endocrinology (Federación Panamericana de Endocrinologia)(FPE), Mexican Society of Nutrition and Endocrinology (Sociedad Mexicana de Nutrición y Endocrinología)(SMNE), Latin American Diabetes Association (Asociación Latinoamericana de Diabetes), Dominican Society of Endocrinology (Sociedad Dominicana de Endocrinología)(SDE), Brazilian Society of Endocrinology and Metabology (Sociedade Brasileira de Endocrinologia e Metabologia)(SBEM), Brazilian Diabetes Society (Sociedade Brasileira de Diabetes )(SBD), Bolivian Society of Endocrinology, Metabolism and Nutrition (Sociedad Boliviana de Endocrinología, Metabolismo y Nutrición)(SBEMN)

Region / CountryGlobal / 全球

JournalPan American Journal of Public Health(Revista Panamericana de Salud Pública)

DOI无

Page Count9

Expert Count25

Conflict of InterestNot stated

Methodology

Recommendation Strength MethodologyA: Metformin + Sulfonylurea; Metformin + Glitazone; B: Metformin + Acarbose; Metformin + Meglitinide; Sulfonylurea + Glitazone; Sulfonylurea + Acarbose; Gliptines + Metformin; Meglitinida + Glitazona

Evidence Level Methodology无

AGREE II Domain Summary

Scope and Purpose86

Stakeholder Involvement50

Rigor of Development38

Clarity of Presentation89

Applicability58

Editorial Independence46